Impact Factor 4.848 | CiteScore 3.5
More on impact ›
The advent of novel targeted therapies and surgical approaches for malignancies of the urinary and male genital tracts have made a significant impact on patient outcomes, and refined the treatment paradigms for these cancers. Preclinical studies, molecular characterization of these tumors, and translational studies have and will continue to provide a major impetus for these developments.
Multispecialty clinical and research groups in Genitourinary (GU) Oncology have focused their clinical and basic research on questions related to the biology and therapy for malignancies arising in the kidney, bladder and male genital tract; however, communication of the results and research findings remains slow and at times a difficult process. Our ultimate goal is to provide a mechanism of communication between clinicians and researchers that will stimulate and promote a continuation of the multimodal strategies characteristic of the genitourinary oncology field.
This section welcomes contributions related to both clinical and basic research findings in the various genitourinary malignancies spanning the following topics:
Descriptive studies (e.g. gene expression profiles, or transcript, protein, or metabolite levels under particular conditions or in a particular cell type) and studies consisting solely of bioinformatic investigation of publicly available genomic / transcriptomic data are regrettably not within the scope of this section.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), CLOCKSS
PMCID: all published articles receive a PMCID
Genitourinary Oncology welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Genitourinary Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com